ACADI’s Training Program will train current and future leaders in innovation and provide participants with critical skills in commercialisation, clinical trial design, and translation, combined with diabetes knowledge from consumer, clinical and regulatory perspectives. ACADI graduates will form a national network of innovators, maintaining connections via ACADI alumni which will offer opportunities for ongoing knowledge development.
Our Training Program Lead, Associate Professor Sarah Glastras (endocrinologist), is an experienced early to mid-career clinician scientist, who will oversee the program together with a team of training advisors from each state and territory (NSW: Professor Alicia Jenkins, VIC: Professor John Prins, QLD: Professor Tony Russell, ACT: Professor Chris Nolan WA: Professor Tim Davis, SA: Professor Robert Fitridge, NT: Professor Alan Cass, TAS: Professor John Burgess). ACADI partners participating in the Training Program will be networked with ACADI researchers and platforms, clinicians, healthcare professionals, clinical facilities, and patients to deliver multi-site trials across diverse communities.
Our Training Program will benefit from ACADI’s innovators from industry, research, health services and community developing creative solutions by addressing the complex challenges associated with healthcare innovation and translation. Our initiatives include:
1. Building translational research capability and expertise. ACADI will support new PhD and early career researcher (ECR) Fellowship opportunities. Aboriginal and Torres Strait Islander skills development and training will be supported through reserving PhD and ECR opportunities. The training program will cover commercialisation and research translation. Regular seminars, project presentations, and guest speakers will facilitate knowledge and idea sharing.
2. Professional development activities for clinicians, researchers, and students.
3. Mentoring and masterclasses will be provided to ensure research projects are end-user focused and have commercial potential to build confident, knowledgeable and well-networked future leaders in diabetes.